1 |
|
Konnick, Eric Q.; Erali, Maria; Ashwood, Edward R.; Hillyard, David R. | Comparison of the National Genetics Institute (NGI) HCV Superquant and Roche COBAS Amplicor HCV Monitor, Version 2.0 Assays | Chronic Hepatitis C infection is currently recognized as an important health care problem. It is estimated that nearly 4 million Americans are infected, 15 to 20 percent of whom will eventually develop Cirrhosis. Current treatments for Hepatitis C virus (HCV) are limited to alfa-interferon alone or ... | Cirrhosis; Patients | 2000-04-22 |